
### [MONDO:0019599](http://purl.obolibrary.org/obo/MONDO_0019599)
**Label:** primary lipodystrophy

**Subclasses:** [MONDO:0019555](http://purl.obolibrary.org/obo/MONDO_0019555) (panniculitis and localized lipodystrophy), [MONDO:0016584](http://purl.obolibrary.org/obo/MONDO_0016584) (mandibuloacral dysplasia), [MONDO:0019556](http://purl.obolibrary.org/obo/MONDO_0019556) (pressure-induced localized lipoatrophy), [MONDO:0010020](http://purl.obolibrary.org/obo/MONDO_0010020) (congenital generalized lipodystrophy type 2), [MONDO:0019553](http://purl.obolibrary.org/obo/MONDO_0019553) (drug-induced localized lipodystrophy), [MONDO:0018883](http://purl.obolibrary.org/obo/MONDO_0018883) (Berardinelli-Seip congenital lipodystrophy), [MONDO:0019554](http://purl.obolibrary.org/obo/MONDO_0019554) (idiopathic localized lipodystrophy), [MONDO:0013572](http://purl.obolibrary.org/obo/MONDO_0013572) (Keppen-Lubinsky syndrome), [MONDO:0020089](http://purl.obolibrary.org/obo/MONDO_0020089) (acquired lipodystrophy), [MONDO:0009312](http://purl.obolibrary.org/obo/MONDO_0009312) (lipodystrophy due to peptidic growth factors deficiency), [MONDO:0019552](http://purl.obolibrary.org/obo/MONDO_0019552) (Centrifugal lipodystrophy), [MONDO:0007906](http://purl.obolibrary.org/obo/MONDO_0007906) (familial partial lipodystrophy, Dunnigan type), [MONDO:0015493](http://purl.obolibrary.org/obo/MONDO_0015493) (lipoatrophy with diabetes, leukomelanodermic papules, liver steatosis, and hypertrophic cardiomyopathy), [MONDO:0009557](http://purl.obolibrary.org/obo/MONDO_0009557) (mandibuloacral dysplasia with type a lipodystrophy), [MONDO:0017230](http://purl.obolibrary.org/obo/MONDO_0017230) (autosomal semi-dominant severe lipodystrophic laminopathy), [MONDO:0009910](http://purl.obolibrary.org/obo/MONDO_0009910) (Wiedemann-Rautenstrauch syndrome), [MONDO:0019193](http://purl.obolibrary.org/obo/MONDO_0019193) (acquired generalized lipodystrophy), [MONDO:0019194](http://purl.obolibrary.org/obo/MONDO_0019194) (localized lipodystrophy), [MONDO:0020087](http://purl.obolibrary.org/obo/MONDO_0020087) (genetic lipodystrophy), [MONDO:0020088](http://purl.obolibrary.org/obo/MONDO_0020088) (familial partial lipodystrophy), [MONDO:0010026](http://purl.obolibrary.org/obo/MONDO_0010026) (short syndrome), [MONDO:0012104](http://purl.obolibrary.org/obo/MONDO_0012104) (partial acquired lipodystrophy), [MONDO:0014402](http://purl.obolibrary.org/obo/MONDO_0014402) (severe neurodegenerative syndrome with lipodystrophy), [MONDO:0013478](http://purl.obolibrary.org/obo/MONDO_0013478) (PLIN1-related familial partial lipodystrophy), [MONDO:0012923](http://purl.obolibrary.org/obo/MONDO_0012923) (congenital generalized lipodystrophy type 3), [MONDO:0011976](http://purl.obolibrary.org/obo/MONDO_0011976) (lipodystrophy-intellectual disability-deafness syndrome), [MONDO:0014431](http://purl.obolibrary.org/obo/MONDO_0014431) (LIPE-related familial partial lipodystrophy), [MONDO:0012074](http://purl.obolibrary.org/obo/MONDO_0012074) (mandibuloacral dysplasia with type b lipodystrophy), [MONDO:0014098](http://purl.obolibrary.org/obo/MONDO_0014098) (CIDEC-related familial partial lipodystrophy), [MONDO:0012072](http://purl.obolibrary.org/obo/MONDO_0012072) (familial partial lipodystrophy, KC6bberling type), [MONDO:0012071](http://purl.obolibrary.org/obo/MONDO_0012071) (congenital generalized lipodystrophy type 1), [MONDO:0019192](http://purl.obolibrary.org/obo/MONDO_0019192) (AKT2-related familial partial lipodystrophy), [MONDO:0013225](http://purl.obolibrary.org/obo/MONDO_0013225) (congenital generalized lipodystrophy type 4), [MONDO:0011448](http://purl.obolibrary.org/obo/MONDO_0011448) (PPARG-related familial partial lipodystrophy), 

**Corr. equiv. classes:** [Orphanet:280356](http://www.orpha.net/ORDO/Orphanet_280356), [Orphanet:156156](http://www.orpha.net/ORDO/Orphanet_156156), [OMIM:151660](http://purl.obolibrary.org/obo/OMIM_151660), [OMIM:608709](http://purl.obolibrary.org/obo/OMIM_608709), [OMIM:248370](http://purl.obolibrary.org/obo/OMIM_248370), [Orphanet:1979](http://www.orpha.net/ORDO/Orphanet_1979), [OMIM:615924](http://purl.obolibrary.org/obo/OMIM_615924), [Orphanet:2348](http://www.orpha.net/ORDO/Orphanet_2348), [Orphanet:280365](http://www.orpha.net/ORDO/Orphanet_280365), [Orphanet:435628](http://www.orpha.net/ORDO/Orphanet_435628), [OMIM:608612](http://purl.obolibrary.org/obo/OMIM_608612), [Orphanet:50811](http://www.orpha.net/ORDO/Orphanet_50811), [OMIM:233805](http://purl.obolibrary.org/obo/OMIM_233805), [OMIM:269700](http://purl.obolibrary.org/obo/OMIM_269700), [Orphanet:435660](http://www.orpha.net/ORDO/Orphanet_435660), [Orphanet:90160](http://www.orpha.net/ORDO/Orphanet_90160), [OMIM:613877](http://purl.obolibrary.org/obo/OMIM_613877), [OMIM:264090](http://purl.obolibrary.org/obo/OMIM_264090), [Orphanet:228429](http://www.orpha.net/ORDO/Orphanet_228429), [Orphanet:2457](http://www.orpha.net/ORDO/Orphanet_2457), [OMIM:608600](http://purl.obolibrary.org/obo/OMIM_608600), [OMIM:604367](http://purl.obolibrary.org/obo/OMIM_604367), [Orphanet:363400](http://www.orpha.net/ORDO/Orphanet_363400), [OMIM:614098](http://purl.obolibrary.org/obo/OMIM_614098), [OMIM:615980](http://purl.obolibrary.org/obo/OMIM_615980), [Orphanet:435651](http://www.orpha.net/ORDO/Orphanet_435651), [Orphanet:90157](http://www.orpha.net/ORDO/Orphanet_90157), [Orphanet:90158](http://www.orpha.net/ORDO/Orphanet_90158), [Orphanet:90159](http://www.orpha.net/ORDO/Orphanet_90159), [OMIM:613327](http://purl.obolibrary.org/obo/OMIM_613327), [Orphanet:90153](http://www.orpha.net/ORDO/Orphanet_90153), [Orphanet:90154](http://www.orpha.net/ORDO/Orphanet_90154), [Orphanet:3455](http://www.orpha.net/ORDO/Orphanet_3455), [Orphanet:90156](http://www.orpha.net/ORDO/Orphanet_90156), [OMIM:269880](http://purl.obolibrary.org/obo/OMIM_269880), [Orphanet:3163](http://www.orpha.net/ORDO/Orphanet_3163), [Orphanet:79083](http://www.orpha.net/ORDO/Orphanet_79083), [Orphanet:79084](http://www.orpha.net/ORDO/Orphanet_79084), [OMIM:615238](http://purl.obolibrary.org/obo/OMIM_615238), [Orphanet:79085](http://www.orpha.net/ORDO/Orphanet_79085), [Orphanet:79086](http://www.orpha.net/ORDO/Orphanet_79086), [Orphanet:98305](http://www.orpha.net/ORDO/Orphanet_98305), [Orphanet:79087](http://www.orpha.net/ORDO/Orphanet_79087), [Orphanet:79088](http://www.orpha.net/ORDO/Orphanet_79088), [Orphanet:528](http://www.orpha.net/ORDO/Orphanet_528), [Orphanet:98306](http://www.orpha.net/ORDO/Orphanet_98306), [OMIM:612526](http://purl.obolibrary.org/obo/OMIM_612526), [Orphanet:98307](http://www.orpha.net/ORDO/Orphanet_98307), [OMIM:608154](http://purl.obolibrary.org/obo/OMIM_608154), [OMIM:608594](http://purl.obolibrary.org/obo/OMIM_608594), 

**Class expressions from DL-Learner:**

- [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 78.77%
- [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 69.85%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 69.85%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 69.85%
- [HP:0009124](http://purl.obolibrary.org/obo/HP_0009124) (Abnormality of adipose tissue) 68.43%
- [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 67.77%
- [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 65.59%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) 65.00%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) 64.82%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 64.51%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 64.51%
- [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 64.30%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) 64.30%
- [HP:0000819](http://purl.obolibrary.org/obo/HP_0000819) (Diabetes mellitus) and [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) 64.00%
- [HP:0001001](http://purl.obolibrary.org/obo/HP_0001001) (Abnormality of subcutaneous fat tissue) and [HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 64.00%


